Citigroup
SVNT

Citigroup’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Citigroup’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-64,415
Closed -$40K – 7424
2013
Q3 		$40K Sell
64,415
-6,729
-9% -$4.3K ﹤0.01% 5455
2013
Q2 		$39K Buy
+71,144
New +$49.6K ﹤0.01% 5530

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citigroup's SVNT Position: Q4 2013 in Review

Citigroup sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 64,415 shares — an estimated $40K sold.

Citigroup first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $40K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Citigroup reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Citigroup sold 64,415 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $40K.
  • Citigroup first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Citigroup's SAVIENT PHARMACEUTICALS INC position peaked at $40K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Citigroup's 13F filing for Q4 2013, filed 14 Feb 2014.